Nwam LLC Purchases New Position in Astera Labs, Inc. $ALAB

Nwam LLC acquired a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, HoldingsChannel reports. The firm acquired 1,861 shares of the company’s stock, valued at approximately $168,000.

Other hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in shares of Astera Labs by 0.9% in the 1st quarter. Vanguard Group Inc. now owns 9,297,476 shares of the company’s stock worth $554,780,000 after purchasing an additional 85,846 shares during the period. Alliancebernstein L.P. raised its stake in Astera Labs by 114.2% in the first quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company’s stock worth $501,289,000 after buying an additional 4,478,741 shares in the last quarter. Atreides Management LP lifted its holdings in Astera Labs by 153.3% in the first quarter. Atreides Management LP now owns 4,652,264 shares of the company’s stock worth $277,601,000 after buying an additional 2,815,614 shares during the period. Fred Alger Management LLC grew its holdings in shares of Astera Labs by 13.0% during the 1st quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock worth $93,087,000 after acquiring an additional 179,638 shares during the period. Finally, FengHe Fund Management Pte. Ltd. purchased a new position in shares of Astera Labs during the 2nd quarter worth approximately $106,772,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Stock Down 8.4%

ALAB opened at $144.47 on Friday. The stock has a market capitalization of $24.40 billion, a price-to-earnings ratio of 130.15, a PEG ratio of 2.94 and a beta of 1.37. The firm has a 50 day moving average price of $194.44 and a 200-day moving average price of $142.70. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.10. The business had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The firm’s revenue was up 103.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on ALAB. Needham & Company LLC increased their price objective on Astera Labs from $205.00 to $220.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Astera Labs in a research report on Wednesday, October 8th. Wall Street Zen cut shares of Astera Labs from a “buy” rating to a “hold” rating in a research report on Tuesday. Bank of America assumed coverage on shares of Astera Labs in a report on Friday, October 3rd. They issued a “neutral” rating and a $230.00 price objective on the stock. Finally, Zacks Research downgraded shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 6th. Thirteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and a consensus price target of $181.59.

Insider Activity at Astera Labs

In other news, CFO Michael Truett Tate sold 18,861 shares of the stock in a transaction that occurred on Monday, August 18th. The shares were sold at an average price of $183.51, for a total value of $3,461,182.11. Following the transaction, the chief financial officer owned 259,512 shares in the company, valued at $47,623,047.12. This represents a 6.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Jitendra Mohan sold 91,441 shares of the firm’s stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the completion of the transaction, the chief executive officer directly owned 2,170,877 shares in the company, valued at approximately $398,377,638.27. The trade was a 4.04% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 434,480 shares of company stock valued at $77,881,380 in the last 90 days. 12.50% of the stock is owned by company insiders.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.